Inventor · disambiguated record
Aaron Martin
Also filed as: MARTIN AARON · MARTIN AARON DAVID
10 granted patents·23 pending applications·14 citations·filing 2010–2025
85Inventor score
Top patents by PatentIndex Score
33 records- 0195US10800833B2Co-stimulatory domains for use in genetically-modified cellsPREC BIOSCIENCES INC·Filed 2019·Granted Oct 13, 2020·7 cites·23 claims
- 0291US11384335B2Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)PREC BIOSCIENCES INC·Filed 2021·Granted Jul 12, 2022·1 cites·3 claims
- 0390US11453861B2Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)PREC BIOSCIENCES INC·Filed 2022·Granted Sep 27, 2022·1 cites·8 claims
- 0490US11008548B2Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)PREC BIOSCIENCES INC·Filed 2020·Granted May 18, 2021·2 cites·3 claims
- 0589US11186822B2Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)PREC BIOSCIENCES INC·Filed 2021·Granted Nov 30, 2021·1 cites·3 claims
- 0685US11286291B2Co-stimulatory domains for use in genetically-modified cellsPREC BIOSCIENCES INC·Filed 2017·Granted Mar 29, 2022·2 cites·28 claims
- 0784US2024084252A1Genetically-modified immune cells comprising a microrna-adapted shrna (shrnamir)PREC BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0882US2024018215A1Co-stimulatory domains for use in genetically-modified cellsPREC BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0981US11851680B2Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)PREC BIOSCIENCES INC·Filed 2022·Granted Dec 26, 2023·0 cites·3 claims
- 1079US2024052373A1Engineered meganucleases with recognition sequences found in the human beta-2 microglobulin genePREC BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1174US2022273778A1Method of inducing antigen-specific tolerance in a subject by administering a composition comprising an apoptotic body surrogate and coupled immunodominant antigenic epitopes associated with autoimmune diseaseUNIV NORTHWESTERN·Filed 2021·Application pending·0 cites
- 1273US2025154460A1Genetically-modified immune cells comprising a microrna-adapted shrna (shrnamir)PREC BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1372US2020046816A1Compositions and Methods for Antigen-Specific ToleranceUNIV NORTHWESTERN·Filed 2019·Application pending·0 cites
- 1472US2022143160A1Compositions Comprising Apoptotic Signaling and Methods for Induction of Antigen-Specific ToleranceUNIV NORTHWESTERN·Filed 2022·Application pending·0 cites
- 1571US2025387461A1Compositions and methods for antigen-specific toleranceUNIV NORTHWESTERN·Filed 2025·Application pending·0 cites
- 1669US2020399346A1Co-stimulatory domains for use in genetically-modified cellsPREC BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1768US10745665B2Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereofPREC BIOSCIENCES INC·Filed 2019·Granted Aug 18, 2020·0 cites·2 claims
- 1867US2015150996A1Compositions and methods for antigen-specific toleranceUNIV NORTHWESTERN·Filed 2013·Application pending·0 cites
- 1966US2021032664A1Engineered meganucleases with recognition sequences found in the human beta-2 microglobulin genePREC BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2066US2022228115A1Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereofPREC BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2160US2025127811A1Modulation of tgf beta signaling in genetically-modified eukaryotic cellsPREC BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2259US2019017075A1Engineered meganucleases with recognition sequences found in the human beta-2 microglobulin genePREC BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 2359US2020339952A1Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereofPREC BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2459US2019365877A1Compositions Comprising Apoptotic Signaling and Methods for Induction of Antigen-Specific ToleranceUNIV NORTHWESTERN·Filed 2019·Application pending·0 cites
- 2555US2023190780A1Methods for immunotherapyPREC BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2653US2023036065A1Methods for cancer immunotherapyPREC BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2753US2022411479A1Cd20 chimeric antigen receptors and methods of use for immunotherapyPREC BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2849US2016166664A1Compositions and methods for induction of antigen-specific toleranceUNIV NORTHWESTERN·Filed 2015·Application pending·0 cites
- 2947US2012076831A1Compositions and methods for induction of antigen-specific toleranceMILLER STEPHEN·Filed 2010·Application pending·0 cites
- 3046US2022204994A1Methods of preparing populations of genetically-modified immune cellsPREC BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 3140US2019003957A1Method for thermal control during surface plasmon resonance analysisPALL CORP·Filed 2017·Application pending·0 cites
- 3239US10724950B2Analysis method for interpreting Taylor dispersion dataSARTORIUS BIOANALYTICAL INSTR INC·Filed 2016·Granted Jul 28, 2020·0 cites·16 claims
- 3339US10564093B2Single injection competition assaysMOLECULAR DEVICES LLC·Filed 2016·Granted Feb 18, 2020·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Aaron Martin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →